PFG Advisors acquired a new stake in CME Group Inc (NASDAQ:CME) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 7,400 shares of the financial services provider’s stock, valued at approximately $1,324,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. Sheaff Brock Investment Advisors LLC boosted its holdings in CME Group by 0.3% in the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock valued at $4,146,000 after purchasing an additional 60 shares during the period. Dorsey & Whitney Trust CO LLC boosted its holdings in CME Group by 1.4% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock valued at $860,000 after purchasing an additional 65 shares during the period. Private Trust Co. NA boosted its holdings in CME Group by 1.9% in the 4th quarter. Private Trust Co. NA now owns 3,488 shares of the financial services provider’s stock valued at $656,000 after purchasing an additional 66 shares during the period. Front Barnett Associates LLC boosted its holdings in CME Group by 5.4% in the 4th quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock valued at $267,000 after purchasing an additional 73 shares during the period. Finally, Ascension Asset Management LLC boosted its holdings in CME Group by 0.6% in the 4th quarter. Ascension Asset Management LLC now owns 12,385 shares of the financial services provider’s stock valued at $2,330,000 after purchasing an additional 75 shares during the period. Hedge funds and other institutional investors own 84.84% of the company’s stock.

In other CME Group news, CFO John W. Pietrowicz sold 17,960 shares of the stock in a transaction dated Wednesday, January 2nd. The shares were sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the sale, the chief financial officer now owns 44,780 shares of the company’s stock, valued at approximately $8,370,277.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Ronald A. Pankau sold 200 shares of the stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $182.90, for a total transaction of $36,580.00. Following the sale, the director now directly owns 3,600 shares in the company, valued at approximately $658,440. The disclosure for this sale can be found here. Insiders have sold a total of 43,949 shares of company stock valued at $7,885,404 in the last quarter. 0.43% of the stock is currently owned by corporate insiders.

Shares of CME Group stock opened at $163.32 on Wednesday. The stock has a market cap of $58.74 billion, a P/E ratio of 23.95, a PEG ratio of 2.09 and a beta of 0.31. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.15. CME Group Inc has a 12-month low of $153.90 and a 12-month high of $197.08.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.02. The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The firm’s revenue for the quarter was up 37.4% on a year-over-year basis. During the same quarter last year, the company posted $1.12 EPS. As a group, equities research analysts forecast that CME Group Inc will post 7.02 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Monday, March 25th. Investors of record on Friday, March 8th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, March 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.84%. This is a boost from CME Group’s previous quarterly dividend of $0.70. CME Group’s dividend payout ratio (DPR) is 43.99%.

A number of analysts have weighed in on the stock. Barclays reduced their price target on shares of CME Group from $210.00 to $193.00 and set an “overweight” rating for the company in a report on Tuesday. JPMorgan Chase & Co. reduced their price target on shares of CME Group from $164.00 to $150.00 and set an “underweight” rating for the company in a report on Friday, March 22nd. BidaskClub cut shares of CME Group from a “sell” rating to a “strong sell” rating in a research note on Friday, March 22nd. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 20th. Finally, Deutsche Bank dropped their price objective on shares of CME Group from $220.00 to $214.00 and set a “buy” rating for the company in a research note on Friday, March 15th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and six have assigned a buy rating to the company. CME Group currently has an average rating of “Hold” and a consensus price target of $191.93.

ILLEGAL ACTIVITY WARNING: “PFG Advisors Takes $1.32 Million Position in CME Group Inc (CME)” was published by Watch List News and is the property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/pfg-advisors-takes-1-32-million-position-in-cme-group-inc-cme/2921800.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Technical Analysis of Stocks and What It Means

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.